Re-evaluating granulation tissue: pathological waste or biological reservoir?

In periodontology and implant surgery — whether for alveolar ridge preservation, GBR, or peri-implantitis treatment — the systematic excision of granulation tissue is the standard. This dogma is based on the idea that this reactive tissue is a pathogenic residue hindering healing. However, this study highlights that its cellular biology remains largely unknown, questioning its status: simple waste or active biological reservoir? The objective here is to define whether this tissue possesses an intrinsic regenerative potential capable of supporting bone formation.

The authors test a bold hypothesis: granulation tissue is the material expression of an immune response, largely composed of alveolar bone demineralized in situ by chronic infection. According to this theory, this tissue acts as an autologous analogue of demineralized bone matrix (DBM). The study postulates that despite inflammation, it harbors populations of mesenchymal stem cells (MSCs) retaining their osteogenic competence. If this identity as "natural DBM" is confirmed, the clinical corollary would require rigorous debridement of the infected surface while scrupulously preserving the reactive tissue during our oral surgery procedures.

Methodology: a paradigm shift based on the DBM hypothesis

This publication presents a conceptual study design for clinical and biological hypothesis formulation. The authors analyze the properties of granulation and reactive tissues from three major surgical contexts: periodontology, implantology (treatment of peri-implantitis), and guided bone regeneration procedures (notably socket preservation).

The experimental and theoretical framework is based on the following elements:

• Biological modeling: Comparison of granulation tissue with demineralized bone matrix (DBM). The study builds on the auto-induction mechanism established by Urist in 1965 to postulate that alveolar bone demineralized in situ by chronic infection constitutes a regenerative reservoir.
• Cellular characterization: Analysis of mesenchymal stem cell (MSC) populations present in inflammatory tissues and evaluation of their differentiation capacity toward the osteogenic lineage.
• Proposed clinical protocol: A selective debridement model consisting of thoroughly cleaning the infected surface (root or implant) while preserving the surrounding reactive tissue, unlike conventional total excision protocols.

The study evaluates the persistence of dental mesenchymal stem cell function despite an inflammatory environment, while acknowledging a reduced mineralization capacity. The authors formulate falsifiable predictions based on their clinical observations to validate this "demineralized bone matrix" identity attributed to granulation tissue.

Results: An underestimated biological reservoir

The study challenges the systematic resection of granulation tissue (GT) by demonstrating that it is not merely inflammatory debris, but a biologically active tissue. The authors rely on several key observations regarding the cell biology of these reactive tissues in periodontal, peri-implant, and alveolar contexts.

Cellular characterization and regenerative potential

The reported analyses highlight the presence of specific cellular populations within the inflammatory tissue, retaining fundamental properties despite the pathology:

• Presence of MSCs: Inflammatory granulation tissue contains populations of mesenchymal stem cell (MSC) types.
• Osteogenic differentiation: Cells derived from these tissues retain the ability to differentiate along the osteogenic lineage.
• In vivo bone formation: The study reports that these cells actively contribute to bone formation in experimental models.
• Persistent functionality: Although the mineralization capacity is described as quantitatively reduced compared to healthy tissues, inflamed dental MSCs maintain their stem cell function.

Analogy with demineralized bone matrix (DBM)

The central hypothesis is based on the identification of granulation tissue as a DBM analogue. The authors suggest that chronic infection causes in situ demineralization of the alveolar bone, transforming the reactive tissue into a self-inducing regenerative reservoir.

Note: The authors specify that while the osteogenic potential is proven, the formal histological identity between granulation tissue and DBM remains a hypothesis to be confirmed by further studies, with current evidence being described as emerging.

Granulation tissue: from surgical waste to biological reservoir

This study challenges the dogma of radical curettage in periodontology and implantology. The authors suggest that granulation tissue, far from being a pathological debris hindering healing, constitutes an active reservoir of mesenchymal stem cells (MSCs). The central hypothesis is that this tissue represents a form of demineralised bone matrix (DBM) produced in situ by chronic infection. Although inflammation reduces the mineralisation capacity of MSCs, the study highlights that they retain their stemness and osteogenic competence, allowing for regenerative auto-induction consistent with the mechanisms described by Urist.

A clinical hypothesis with assumed limits

The weak point of this study lies in its theoretical status: the histological identity between granulation tissue and DBM remains a hypothesis to be confirmed and not an established fact. However, the authors rely on clinical observations to suggest that debridement should be selective. Contrary to the traditional approach aiming for the total elimination of reactive tissue, this study suggests that meticulous cleaning of the infected surface (root or implant) coupled with the preservation of granulation tissue could optimize regeneration.

Study summary

This study proposes that periodontal and peri-implant granulation tissue is not inflammatory waste, but an active biological reservoir containing mesenchymal stem cells (MSCs) capable of osteogenic differentiation. The central hypothesis equates this tissue to an in situ demineralized bone matrix (DBM), retaining its osteoinductive potential despite chronic infection.

In concrete terms, for the practitioner:

• Preserve reactive tissue: During periodontology surgeries or peri-implantitis treatments, focus mechanical debridement on rigorous decontamination of hard surfaces (roots, implants) while avoiding systematic and aggressive excision of granulation tissue.
• Leverage endogenous potential: Consider this tissue as a natural "regenerative matrix" already in place, capable of supporting bone formation thanks to its resident cell populations.
• Nuance the curettage: If the pathogenicity of the surface must be eliminated, the adjacent inflammatory soft tissue can be a therapeutic ally rather than an obstacle to healing.

Technical lexicon of the study

Granulation and reactive tissue: Inflammatory tissue classically curetted during periodontal and implant surgeries, but here reconsidered as an active biological reservoir containing cell populations with regenerative potential.

Demineralized Bone Matrix (DBM): Bone structure from which the mineral phase has been removed, releasing osteoinductive growth factors. The study postulates that granulation tissue is a DBM analogue, created in situ by the demineralization of the alveolar bone under the effect of chronic infection.

Auto-induction: Biological mechanism identified by Urist in 1965, by which the components of the demineralized bone matrix induce the differentiation of stem cells into bone cells.

Osteogenic lineage: Specialized differentiation pathway that mesenchymal stem cells present in inflamed granulation tissue are capable of following to contribute to bone formation in vivo.

Mesenchymal stem cells (MSC-like): Cell populations identified in inflamed periodontal and peri-implant tissues that retain their basic functions, although their mineralization capacity may be diminished by the inflammatory environment.

Immune mediation: Process by which the destruction of periodontal tissues is orchestrated by the immune system, making granulation tissue the material expression of this immunological response rather than simple pathological waste.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.